FARMORUBICIN Side Effects

7023326-4 | Panniculitis
on Sep 22, 2010 Male patient from JAPAN , 73 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: panniculitis. Farmorubicin dosage: . During the same period patient was treated with LIPIODOL (View Lipiodol Review and Lipiodol Label ). Patient was hospitalized.

6988543-8 | Febrile Neutropenia, Tonsillitis
Patient was taking Farmorubicin (View Usage). Patient had the following side effects: febrile neutropenia, tonsillitis on Sep 07, 2010 from GREECE Additional patient health information: Female patient , 28 years of age, weighting 108.0 lb, was diagnosed with breast cancer (What is breast cancer?), neutropenia and. Farmorubicin dosage: 160 Mg, Every 2 Weeks. During the same period patient was treated with NEULASTA (10 Mg/d2, Weekly) (View Neulasta Review and Neulasta Label ), ZOFRON (8 Mg, Unk) (View Zofron Review and Zofron Label ), PRIMPERAN TAB (10 Mg, Unk) (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6917631-7 | Interstitial Lung Disease
Adverse event was reported on Jul 29, 2010 by a Female patient taking Farmorubicin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 47 years of age, After Farmorubicin was administered, patient had the following side effects: interstitial lung disease. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ).

6917630-5 | Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia
on Jul 29, 2010 Female patient from JAPAN , 51 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pneumocystis jiroveci pneumonia. Farmorubicin dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL (Weekly) (View Paclitaxel Review and Paclitaxel Label ). Patient was hospitalized.


6917629-9 | Interstitial Lung Disease
on Jul 29, 2010 Female patient from JAPAN , 48 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicin (View Usage). Patient had the following side effects: interstitial lung disease. Farmorubicin dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL (Unk) (View Paclitaxel Review and Paclitaxel Label ).

6822725-0 | Diverticulitis
Patient was taking Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: diverticulitis on Jun 28, 2010 from GERMANY Additional patient health information: Female patient , 54 years of age, . Farmorubicin dosage: .

6822715-8 | Colitis Ischaemic, Haemorrhage
Adverse event was reported on Jun 28, 2010 by a Female patient taking Farmorubicin (View Usage) (Dosage: ) . Location: GERMANY , 62 years of age, Patient experienced the following unwanted or unexpected effects: colitis ischaemic, haemorrhage.

6803005-6 | Interstitial Lung Disease, Neutrophil Count Decreased
on Jun 15, 2010 Female patient from JAPAN , 53 years of age, weighting 150.4 lb, was diagnosed with breast cancer (What is breast cancer?), antiemetic supportive care, cancer pain, gastritis, neutrophil count decreased and was treated with Farmorubicin (View Usage). Patient had the following side effects: interstitial lung disease, neutrophil count decreased. Farmorubicin dosage: 120 Mg, 1x/day. During the same period patient was treated with FLUOROURACIL (800 Mg, 1x/day) (View Fluorouracil Review and Fluorouracil Label ), ENDOXAN (800 Mg, 1x/day) (View Endoxan Review and Endoxan Label ), SEROTONE (10 Mg, 1x/day) (View Serotone Review and Serotone Label ), DECADRON (6.6 Mg) (View Decadron Review and Decadron Label ), LOXOPROFEN SODIUM (60 Mg, 3x/day) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), MUCOSTA (100 Mg, 3x/day) (View Mucosta Review and Mucosta Label ), NEUTROGIN (100 Ug, 1x/day) (View Neutrogin Review and Neutrogin Label ). Patient was hospitalized.

6766279-6 | Abdominal Pain Upper, Anaphylactic Reaction, Blood Pressure Decreased, Bradycardia, Chest Discomfort, Feeling Abnormal
on May 27, 2010 Female patient from JAPAN , 77 years of age, weighting 110.8 lb, was diagnosed with hepatic neoplasm malignant, preoperative care, chest discomfort, abdominal pain upper and was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: abdominal pain upper, anaphylactic reaction, blood pressure decreased, bradycardia, chest discomfort, feeling abnormal. Farmorubicin dosage: 30 Mg, 1x/day. During the same period patient was treated with LIPIODOL (5 Ml, 1x/day) (View Lipiodol Review and Lipiodol Label ), IOMERON ^EISAI^ (3 Ml, 1x/day) (View Iomeron ^eisai^ Review and Iomeron ^eisai^ Label ), SOSEGON INJECTION (15 Mg, 2x/day) (View Sosegon Injection Review and Sosegon Injection Label ), ATARAX (25 Mg, 2x/day) (View Atarax Review and Atarax Label ), METHYLPREDNISOLONE SODIUM SUCCINATE (500 Mg, 2x/day) (View Methylprednisolone Sodium Succinate Review and Methylprednisolone Sodium Succinate Label ).

6764355-5 | Eczema, Febrile Neutropenia, Interstitial Lung Disease
Patient was taking Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?), febrile neutropenia, interstitial lung disease on May 31, 2010 from JAPAN Additional patient health information: Female patient , 66 years of age, weighting 132.3 lb, was diagnosed with breast cancer (What is breast cancer?), febrile neutropenia, procedural pain, vomiting and. Farmorubicin dosage: 118.5 Mg, 1x/day. During the same period patient was treated with ENDOXAN (948 Mg, 1x/day) (View Endoxan Review and Endoxan Label ), GRAN (Unk) (View Gran Review and Gran Label ), CRAVIT (View Cravit Review and Cravit Label ), LORCAM (Unk) (View Lorcam Review and Lorcam Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), SEROTONE (Unk) (View Serotone Review and Serotone Label ), DECADRON (Unk) (View Decadron Review and Decadron Label ), NAUZELIN (Unk) (View Nauzelin Review and Nauzelin Label ). Patient was hospitalized.

6732100-5 | Eczema, Febrile Neutropenia, Interstitial Lung Disease
Adverse event was reported on May 11, 2010 by a Female patient taking Farmorubicin (View Usage) (Dosage: 118.5 Mg, 1x/day) was diagnosed with breast cancer (What is breast cancer?), febrile neutropenia, procedural pain, vomiting and. Location: JAPAN , 66 years of age, weighting 132.3 lb, Patient had the following side effects: eczema (What is eczema?), febrile neutropenia, interstitial lung disease. During the same period patient was treated with ENDOXAN (948 Mg, 1x/day) (View Endoxan Review and Endoxan Label ), GRAN (Unk) (View Gran Review and Gran Label ), CRAVIT (View Cravit Review and Cravit Label ), LORCAM (Unk) (View Lorcam Review and Lorcam Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), SEROTONE (Unk) (View Serotone Review and Serotone Label ), DECADRON (Unk) (View Decadron Review and Decadron Label ), NAUZELIN (Unk) (View Nauzelin Review and Nauzelin Label ).

6728653-3 | Blood Pressure Decreased, Bradycardia, Chest Discomfort, Feeling Abnormal
on May 06, 2010 Female patient from JAPAN , 77 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: blood pressure decreased, bradycardia, chest discomfort, feeling abnormal. Farmorubicin dosage: 15 Mg, Once. During the same period patient was treated with LIPIODOL (View Lipiodol Review and Lipiodol Label ).

6717701-2 | Hepatitis B
on Apr 28, 2010 Female patient from JAPAN , 45 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). Farmorubicin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6716176-7 | Acute Promyelocytic Leukaemia, Ascites, Neoplasm Malignant
Patient was taking Farmorubicin (View Usage). Patient had the following side effects: acute promyelocytic leukaemia, ascites, neoplasm malignant on Apr 26, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, weighting 130.1 lb, was diagnosed with hepatic neoplasm malignant and. Farmorubicin dosage: 60 Mg, 1x/day. During the same period patient was treated with LIPIODOL ULTRA FLUID (Unk) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), URSO 250 (Unk) (View Urso 250 Review and Urso 250 Label ), STRONG NEO MINOPHAGEN C (Unk) (View Strong Neo-minophagen C Review and Strong Neo-minophagen C Label ), GRAN (Unk) (View Gran Review and Gran Label ). Patient was hospitalized.

6706740-3 | Blood Pressure Decreased, Bradycardia, Chest Discomfort, Feeling Abnormal
Adverse event was reported on Apr 21, 2010 by a Female patient taking Farmorubicin (View Usage) (Dosage: 15 Mg, Once) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 77 years of age, After Farmorubicin was administered, patient had the following side effects: blood pressure decreased, bradycardia, chest discomfort, feeling abnormal. During the same period patient was treated with LIPIODOL (View Lipiodol Review and Lipiodol Label ).

6706738-5 | Interstitial Lung Disease
on Apr 21, 2010 Female patient from JAPAN , 53 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Farmorubicin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6697147-6 | Eczema, Febrile Neutropenia, Interstitial Lung Disease
on Apr 14, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with breast cancer (What is breast cancer?), febrile neutropenia and was treated with Farmorubicin (View Usage). Patient had the following side effects: eczema (What is eczema?), febrile neutropenia, interstitial lung disease. Farmorubicin dosage: 75 Mg/m2, Unk. During the same period patient was treated with GRAN (Unk) (View Gran Review and Gran Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), CRAVIT (View Cravit Review and Cravit Label ), LORCAM (View Lorcam Review and Lorcam Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ). Patient was hospitalized.

6682420-8 | Eczema, Febrile Neutropenia, Interstitial Lung Disease
Patient was taking Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: eczema (What is eczema?), febrile neutropenia, interstitial lung disease on Apr 06, 2010 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with breast cancer (What is breast cancer?), febrile neutropenia and. Farmorubicin dosage: 75 Mg/m2, Unk. During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), CRAVIT (View Cravit Review and Cravit Label ), LORCAM (View Lorcam Review and Lorcam Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

6678730-0 |
Adverse event was reported on Apr 01, 2010 by a Female patient taking Farmorubicin (View Usage) (Dosage: 97.2 Mg, Unk) was diagnosed with breast cancer recurrent and. Location: JAPAN , 54 years of age, weighting 143.3 lb, . During the same period patient was treated with CYCLOPHOSPHAMIDE (972 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), BENZALIN (View Benzalin Review and Benzalin Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), SENNOSIDE A+B CALCIUM (View Sennoside A+b Calcium Review and Sennoside A+b Calcium Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6662074-7 | Toxic Epidermal Necrolysis
on Mar 23, 2010 Female patient from JAPAN , 55 years of age, weighting 108.0 lb, was diagnosed with malignant breast lump removal and was treated with Farmorubicin (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Farmorubicin dosage: 145 Mg, Once/3weeks. During the same period patient was treated with CYCLOPHOSPHAMIDE (900 Mg Once/3weeks) (View Cyclophosphamide Review and Cyclophosphamide Label ), FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), POLAPREZINC (Unk) (View Polaprezinc Review and Polaprezinc Label ), MYSLEE (Unk) (View Myslee Review and Myslee Label ).

6657634-3 | Eczema, Febrile Neutropenia, Interstitial Lung Disease
on Mar 18, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with breast cancer (What is breast cancer?), febrile neutropenia and was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: eczema (What is eczema?), febrile neutropenia, interstitial lung disease. Farmorubicin dosage: 75 Mg/m2, Unk. During the same period patient was treated with FILGRASTIM (View Filgrastim Review and Filgrastim Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CRAVIT (View Cravit Review and Cravit Label ), LORCAM (View Lorcam Review and Lorcam Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ).

6644787-6 | Toxic Epidermal Necrolysis
Patient was taking Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis on Mar 10, 2010 from JAPAN Additional patient health information: Female patient , 55 years of age, weighting 108.0 lb, was diagnosed with malignant breast lump removal and. Farmorubicin dosage: 145 Mg, Once/3weeks. During the same period patient was treated with ENDOXAN (900 Mg Once/3weeks) (View Endoxan Review and Endoxan Label ), FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), POLAPREZINC (Unk) (View Polaprezinc Review and Polaprezinc Label ), MYSLEE (Unk) (View Myslee Review and Myslee Label ).

6636223-0 |
Adverse event was reported on Mar 04, 2010 by a Female patient taking Farmorubicin (View Usage) (Dosage: 60 Mg/m2, (90 Mg), Once) was diagnosed with breast cancer recurrent and. Location: JAPAN , 54 years of age, weighting 143.3 lb, . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6596626-X | Blister, Infusion Site Extravasation, Injection Site Erythema, Injection Site Pain
on Feb 11, 2010 Female patient from PORTUGAL , 60 years of age, was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: blister, infusion site extravasation, injection site erythema, injection site pain. Farmorubicin dosage: .

6593851-9 | Toxic Epidermal Necrolysis
on Feb 10, 2010 Female patient from JAPAN , 55 years of age, weighting 108.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Farmorubicin dosage: 145 Mg, Injection. During the same period patient was treated with ENDOXAN (900 Mg) (View Endoxan Review and Endoxan Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), POLAPREZINC (View Polaprezinc Review and Polaprezinc Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

6553924-3 | Pneumocystis Jiroveci Pneumonia
Patient was taking Farmorubicin (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia on Jan 15, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, weighting 107.8 lb, was diagnosed with breast cancer (What is breast cancer?), asthma (What is asthma?), gastric ulcer and. Farmorubicin dosage: 1200 Mg/3weeks Inj. During the same period patient was treated with ENDOXAN (950 Mg/3weeks) (View Endoxan Review and Endoxan Label ), GRANISETRON (3 Mg/3weeks) (View Granisetron Review and Granisetron Label ), DEXAMETHASONE SODIUM PHOSPHATE (12 Mg/3weeks) (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), ONON (Unk) (View Onon Review and Onon Label ), THEO DUR (Unk) (View Theo-dur Review and Theo-dur Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ), FUNGIZONE (Unk) (View Fungizone Review and Fungizone Label ). Patient was hospitalized.

6553920-6 | Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Jan 15, 2010 by a Female patient taking Farmorubicin (View Usage) (Dosage: 70 Mg/day Once Daily) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 35 years of age, weighting 82.01 lb, After Farmorubicin was administered, patient had the following side effects: pneumocystis jiroveci pneumonia. During the same period patient was treated with ENDOXAN (560 Mg/day Twice Daily) (View Endoxan Review and Endoxan Label ), GRAN (300 Mcg/day Four Times Daily) (View Gran Review and Gran Label ), CIPROXAN (2100 Mg/day Seven Times Daily) (View Ciproxan Review and Ciproxan Label ), FERROMIA (Unk) (View Ferromia Review and Ferromia Label ), OXYCONTIN (Unk) (View Oxycontin Review and Oxycontin Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ). Patient was hospitalized.

6553919-X | Pneumocystis Jiroveci Pneumonia
on Jan 15, 2010 Female patient from JAPAN , 46 years of age, weighting 97.00 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia. Farmorubicin dosage: 140 Mg, Inj. During the same period patient was treated with ENDOXAN (800 Mg/day Once Daily) (View Endoxan Review and Endoxan Label ), TAXOTERE (Unk) (View Taxotere Review and Taxotere Label ), TRASTUZUMAB (Unk) (View Trastuzumab Review and Trastuzumab Label ), DECADRON (Unk) (View Decadron Review and Decadron Label ), GRANISETRON (Unk) (View Granisetron Review and Granisetron Label ), GASTER (Unk) (View Gaster Review and Gaster Label ), GANATON (Unk) (View Ganaton Review and Ganaton Label ), MEDICON (Unk) (View Medicon Review and Medicon Label ). Patient was hospitalized.

6531690-5 | Interstitial Lung Disease
on Dec 25, 2009 Female patient from JAPAN , 76 years of age, weighting 176.4 lb, was diagnosed with breast cancer recurrent and was treated with Farmorubicin (View Usage). Patient had the following side effects: interstitial lung disease. Farmorubicin dosage: 129 Mg, Unk. During the same period patient was treated with FLUOROURACIL (860 Mg, Unk) (View Fluorouracil Review and Fluorouracil Label ), ENDOXAN (860 Mg, Unk) (View Endoxan Review and Endoxan Label ), DECADRON (Unk) (View Decadron Review and Decadron Label ), ONDANSETRON (Unk) (View Ondansetron Review and Ondansetron Label ), GASTER (Unk) (View Gaster Review and Gaster Label ). Patient was hospitalized.

6527409-4 | Interstitial Lung Disease
Patient was taking Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: interstitial lung disease on Dec 25, 2009 from JAPAN Additional patient health information: Female patient , 76 years of age, weighting 176.4 lb, was diagnosed with breast cancer recurrent and. Farmorubicin dosage: 129 Mg, Unk. During the same period patient was treated with FLUOROURACIL (860 Mg, Unk) (View Fluorouracil Review and Fluorouracil Label ), ENDOXAN (860 Mg, Unk) (View Endoxan Review and Endoxan Label ), DECADRON (Unk) (View Decadron Review and Decadron Label ), ONDANSETRON (Unk) (View Ondansetron Review and Ondansetron Label ), GASTER (Unk) (View Gaster Review and Gaster Label ). Patient was hospitalized.

6519714-2 | Interstitial Lung Disease
Adverse event was reported on Dec 16, 2009 by a Female patient taking Farmorubicin (View Usage) (Dosage: 129 Mg, Unk) was diagnosed with breast cancer recurrent and. Location: JAPAN , 76 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease. During the same period patient was treated with FLUOROURACIL (860 Mg, Unk) (View Fluorouracil Review and Fluorouracil Label ), ENDOXAN (860 Mg, Unk) (View Endoxan Review and Endoxan Label ), DECADRON (Unk) (View Decadron Review and Decadron Label ), ONDANSETRON (Unk) (View Ondansetron Review and Ondansetron Label ), GASTER (Unk) (View Gaster Review and Gaster Label ). Patient was hospitalized.

6505504-3 | Interstitial Lung Disease
on Dec 07, 2009 Female patient from JAPAN , 75 years of age, was diagnosed with breast cancer recurrent and was treated with Farmorubicin (View Usage). Patient had the following side effects: interstitial lung disease. Farmorubicin dosage: Injection. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6488673-3 | Pneumocystis Jiroveci Pneumonia
on Nov 30, 2009 Female patient from JAPAN , 46 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: pneumocystis jiroveci pneumonia. Farmorubicin dosage: 100 Mg/m2, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (600 Mg/m2, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOCETAXEL (100 Mg/m2, Unk) (View Docetaxel Review and Docetaxel Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6488672-1 | Pneumocystis Jiroveci Pneumonia
Patient was taking Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia on Nov 30, 2009 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Farmorubicin dosage: 75 Mg/m2, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (600 Mg/m2, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6488666-6 | Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Nov 30, 2009 by a Female patient taking Farmorubicin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 35 years of age, Patient had the following side effects: pneumocystis jiroveci pneumonia. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6440216-6 | Dysaesthesia, Hypoaesthesia
on Nov 02, 2009 Female patient from GERMANY , 43 years of age, was diagnosed with breast cancer female and was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: dysaesthesia, hypoaesthesia. Farmorubicin dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ).

6406965-0 | Bacteraemia, Cellulitis, Hepatitis
on Oct 08, 2009 Female patient from JAPAN , 81 years of age, was diagnosed with hepatic neoplasm malignant, back pain (What is back pain?), insomnia and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, cellulitis (What is cellulitis?), hepatitis (What is hepatitis?). Farmorubicin dosage: Tdd: 35 Mg. During the same period patient was treated with LIPIODOL ULTRA FLUID (3.5 Ml) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ), MOHRUS (View Mohrus Review and Mohrus Label ), HALCION (View Halcion Review and Halcion Label ). Patient was hospitalized.

6394942-8 | Dysaesthesia, Hypoaesthesia
Patient was taking Farmorubicin (View Usage). Patient had the following side effects: dysaesthesia, hypoaesthesia on Sep 29, 2009 from GERMANY Additional patient health information: Female patient , 43 years of age, was diagnosed with breast cancer female and. Farmorubicin dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ).

6382411-0 | Skin Disorder
Adverse event was reported on Sep 18, 2009 by a Female patient taking Farmorubicin (View Usage) (Dosage: 20 Mg, 1x/day) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 69 years of age, After Farmorubicin was administered, patient had the following side effects: skin disorder. During the same period patient was treated with GELATIN (1 Mm Daily) (View Gelatin Review and Gelatin Label ), LIPIODOL ULTRA FLUID (10 Ml) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ). Patient was hospitalized.

6344222-1 | Erythema, Peripheral Ischaemia, Purpura, Skin Disorder
on Aug 27, 2009 Female patient from JAPAN , 69 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, peripheral ischaemia, purpura, skin disorder. Farmorubicin dosage: 20 Mg, 1x/day. During the same period patient was treated with GELATIN (1 Mm Daily) (View Gelatin Review and Gelatin Label ), LIPIODOL ULTRA FLUID (10 Ml) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ). Patient was hospitalized.

6322218-3 | Interstitial Lung Disease
on Aug 12, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Farmorubicin (View Usage). Patient had the following side effects: interstitial lung disease. Farmorubicin dosage: 50 Mg, 1x/day. During the same period patient was treated with LIPIODOL (10 Ml, 1x/day) (View Lipiodol Review and Lipiodol Label ), GELATIN (Trace Daily) (View Gelatin Review and Gelatin Label ), PANSPORIN (1 G, 1x/day) (View Pansporin Review and Pansporin Label ), ROPION (50 Mg, 1x/day) (View Ropion Review and Ropion Label ), LEVOFLOXACIN (200 Mg, 2x/day) (View Levofloxacin Review and Levofloxacin Label ), COLONEL (100 Mg, 3x/day) (View Colonel Review and Colonel Label ), STRONG NEO MINOPHAGEN C (40 Ml, 1x/day) (View Strong Neo-minophagen C Review and Strong Neo-minophagen C Label ), OPTIRAY 350 (120 Ml, 1x/day) (View Optiray 350 Review and Optiray 350 Label ).

6313100-6 | Interstitial Lung Disease
Patient was taking Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: interstitial lung disease on Aug 06, 2009 from JAPAN Additional patient health information: Female patient , 53 years of age, was diagnosed with uterine cancer (What is uterine cancer?) and. Farmorubicin dosage: 60 Mg (month). During the same period patient was treated with RANDA (16 Mg; 7x/months) (View Randa Review and Randa Label ), IFOMIDE (1 G; 4x/months) (View Ifomide Review and Ifomide Label ). Patient was hospitalized.

6297792-6 | Hepatic Function Abnormal
Adverse event was reported on Jul 24, 2009 by a Female patient taking Farmorubicin (View Usage) (Dosage: 120 Mg, Every 3 Weeks (tdd: 120 Mg/3 Weeks)) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 37 years of age, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. During the same period patient was treated with FLUOROURACIL (750 Mg, Every 3 Weeks (tdd: 750 Mg/3weeks)) (View Fluorouracil Review and Fluorouracil Label ), ENDOXAN (750 Mg, Every 3 Weeks (tdd: 750 Mg/3 Weeks)) (View Endoxan Review and Endoxan Label ).

6286349-9 | Acute Myocardial Infarction, Cardiogenic Shock, Cytomegalovirus Infection, Pancytopenia, Septic Shock
on Jul 16, 2009 Female patient from JAPAN , 70 years of age, was diagnosed with breast cancer recurrent and was treated with Farmorubicin (View Usage). Patient had the following side effects: acute myocardial infarction, cardiogenic shock, cytomegalovirus infection (What is cytomegalovirus infection?), pancytopenia, septic shock. Farmorubicin dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

6282146-9 | Interstitial Lung Disease, Lung Neoplasm
on Jul 14, 2009 Female patient from JAPAN , 53 years of age, was diagnosed with uterine cancer (What is uterine cancer?) and was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: interstitial lung disease, lung neoplasm. Farmorubicin dosage: 60 Mg (month). During the same period patient was treated with RANDA (16 Mg; 7x/months) (View Randa Review and Randa Label ), IFOMIDE (1 G; 4x/months) (View Ifomide Review and Ifomide Label ). Patient was hospitalized.

6274181-1 | Interstitial Lung Disease, Neutropenia, Pancytopenia, Pulmonary Oedema
Patient was taking Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, neutropenia, pancytopenia, pulmonary oedema on Jul 08, 2009 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Farmorubicin dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), URSO 250 (Unk) (View Urso 250 Review and Urso 250 Label ), LANDEL (Unk) (View Landel Review and Landel Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), OXYCONTIN (Unk) (View Oxycontin Review and Oxycontin Label ), FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), VESICARE (Unk) (View Vesicare Review and Vesicare Label ). Patient was hospitalized.

6273829-5 | Abnormal Sensation In Eye, Convulsion, Myodesopsia, Scintillating Scotoma, Visual Impairment
Adverse event was reported on Jul 08, 2009 by a Female patient taking Farmorubicin (View Usage) (Dosage: 40 Mg, 1x/day) was diagnosed with hepatic neoplasm malignant, angiogram, prophylaxis, postoperative analgesia and. Location: JAPAN , 72 years of age, Patient had the following side effects: abnormal sensation in eye, convulsion, myodesopsia, scintillating scotoma, visual impairment. During the same period patient was treated with LIPIODOL ULTRA FLUID (10 Ml, 1x/day) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ), OPTIRAY 350 (110 Ml, 1x/day) (View Optiray 350 Review and Optiray 350 Label ), CRAVIT (200 Mg, 1x/day) (View Cravit Review and Cravit Label ), PANSPORIN (1 G, 1x/day) (View Pansporin Review and Pansporin Label ), ROPION (50 Mg, 1x/day) (View Ropion Review and Ropion Label ).

6266232-5 | Acute Myocardial Infarction, Cardiogenic Shock, Cytomegalovirus Infection, Pancytopenia, Septic Shock
on Jul 01, 2009 Female patient from JAPAN , 70 years of age, was diagnosed with breast cancer recurrent and was treated with Farmorubicin (View Usage). After Farmorubicin was administered, patient had the following side effects: acute myocardial infarction, cardiogenic shock, cytomegalovirus infection (What is cytomegalovirus infection?), pancytopenia, septic shock. Farmorubicin dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

6258467-2 | Interstitial Lung Disease
on Jun 25, 2009 Female patient from JAPAN , 53 years of age, was diagnosed with uterine cancer (What is uterine cancer?) and was treated with Farmorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Farmorubicin dosage: 60 Mg. During the same period patient was treated with RANDA (Unk) (View Randa Review and Randa Label ), IFOMIDE (Unk) (View Ifomide Review and Ifomide Label ). Patient was hospitalized.

6258434-9 | Bacteraemia, Cellulitis, Hepatitis
Patient was taking Farmorubicin (View Usage). Patient had the following side effects: bacteraemia, cellulitis (What is cellulitis?), hepatitis (What is hepatitis?) on Jun 25, 2009 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with hepatic neoplasm malignant, back pain (What is back pain?), insomnia and. Farmorubicin dosage: Tdd: 35 Mg. During the same period patient was treated with LIPIODOL ULTRA FLUID (3.5 Ml) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ), MOHRUS (View Mohrus Review and Mohrus Label ), HALCION (View Halcion Review and Halcion Label ). Patient was hospitalized.